Challenge on Biomarkers and Treatment for Ovarian Cancer and Cervical Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Biomarkers".
Deadline for manuscript submissions: closed (15 November 2022) | Viewed by 11083
Special Issue Editor
Special Issue Information
Dear Colleagues,
Ovarian cancer is the leading cause of gynecologic cancer death in the United States and Europe, and cervical cancer is the leading cause of gynecologic cancer death worldwide. Biomarkers which can identify women at increased risk for these diseases or that may select individuals for targeted therapies are acutely needed. Tissue, circulating, and imaging markers are needed to triage patients into screening and therapeutic trials. This Special Issue will summarize current data concerning the following topics: early detection, prognostic biomarkers, and targeted therapies for ovarian and cervical cancer.
Dr. Kevin M. Elias
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ovarian cancer
- cervical cancer
- early detection
- biomarkers
- targeted therapy